Second malignancies in patients treated for childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2848-2853

  Kimball Dalton, Virginia M ^a   Gelber, Richard D ^b   Li, Frederick ^b   Donnelly, Mia J ^b   Tarbell, Nancy J ^b   Sallan, Stephen E ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DOXORUBICIN; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASTROCYTOMA; BASAL CELL CARCINOMA; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; MALE; MENINGIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SECOND CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0006706367     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2848     Document Type: Article

References (42)

1. Niemeyer C, Sallan SE: Childhood acute lymphoblastic leukemia, in Nathan DG, Oski FA (eds): Hematology of Infancy and Childhood (ed 5). Philadelphia, PA, Saunders, 1998, pp 1245-1269
2. Green DM: Long-term complications of therapy for cancer in childhood and adolescence. Baltimore, MD, Johns Hopkins University Press, 1989
3. Neglia JP, Meadows AT, Robison LL, et al: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330-1336, 1991
4. Mosijczuk A, Ruymann FB: Second malignancy in acute lymphocytic leukemia. Am J Dis Child 135:313-316, 1981
5. Chessel JM: Childhood acute lymphoblastic leukemia: The late effects of treatment. Br J Hematol 53:369-378, 1983
6. Mike V, Meadows AT, D'Angio GJ: Incidence of second malignant neoplasms in children: Results of an international study. Lancet 1:1326-1331, 1982
7. Li FP, Cassady JR, Jaffe N: Risk of second tumors in survivors of childhood cancer. Cancer 35:1230-1235, 1975
8. Li FP: Second malignant tumors after cancer in childhood. Cancer 40:1899-1902, 1977
9. Kingston JE, Hawkins MM, Drapper GJ, et al: Patterns of multiple primary tumors in patients treated for cancer during childhood. Br J Cancer 56:331-338, 1987
10. Rosso P, Terracini B, Fears TR, et al: Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy. Int J Cancer 59:451-456, 1994
11. Inati A, Sallan SE, Cassady RJ, et al: Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: Eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 61:297-303, 1983
12. Sallan SE, Camitta BM, Cassady JR, et al: Intermittent combination chemotherapy with Adriamycin for childhood acute lymphoblastic leukemia: Clinical results. Blood 51:425-433, 1978
13. Sallan SE, Camitta BM, Frei E, et al: Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): Addition of an anthracycline to vincristine and prednisone. Med Pediatr Oncol 3:281-287, 1977
14. Hilchcock-Bryan S, Gelber R, Cassady JR, et al: The impact of induction anthracycline on long-term disease-free survival in childhood acme lymphoblastic leukemia. Med Pediatr Oncol 14:211-215, 1986
15. Sallan SE, Hitchcock-Bryan S, Gelber R, et al: Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 43:5601-5607, 1983
16. Sallan SE, Gelber RD, Kimball V, et al: More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials. Hematol Blood Trans 33:459-466, 1990
17. Clavell LA, Gelber RD, Cohen HJ, et al: Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315:657-663, 1986
18. Niemeyer CM, Gelber RD, Tarbell NJ, et al: Low-dose verses high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update). Blood 78:2514-2519, 1991
19. Schorin MA, Blattner S, Gelber RD, et al: Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 12:740-747, 1994
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Kalbfleisch J, Prentice R: The statistical analysis of failure time data. New York, NY, Wiley, 1980, p 169
22. Gray RJ: A class of k-sample tests for comparing the cumulative incidence of competing risks. Ann Stat 16:1141-1154, 1988
23. Surveillance, Epidemiology, and End-Result (SEER): Cancer Incidence and Mortality in the United States, 1973-1981. Bethesda, MD, NIH Publication No. 85-1837, 1984
24. Pui CH, Behm FG, Raimondi SC, et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 321:136-142, 1989
25. Tucker MA, Meadows AT, Boice JD, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987
26. Modan B, Baidatz D, Mart H, et al: Radiation-induced head and neck tumours. Lancet 1:227-229, 1974
27. Rimm IJ, Li FC, Tarbell NJ, et al: Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. Cancer 59:1506-1508, 1987
28. Magnani C, Teracini B, DiMontozemoto L, et al: Incidence of second primary malignancy after a malignant tumor in childhood: A population-based survey in Peidmont (Italy). Int J Cancer 67:6-10, 1996
29. Cavin LW, Dalrymple GV, McGuire EL, et al: CNS tumor induction by radiotherapy: A report of four new cases and estimate of dose required. J Radiat Oncol Biol Phy 18:399-406, 1989
30. Shapiro S, Mealey J: Late anaplastic gliomas in children previously treated for acute lymphoblastic leukemia. Pediatr Neurosci 15:176-180, 1989
31. Fontana M, Stanton C, Pompili A, et al: Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia. Cancer 60:1510-1518, 1987
32. Brustle O, Ohgaki H, Schmitt HP, et al: Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Cancer 69:2385-2392, 1991
33. Anderson JR, Treip CS: Radiation-induced intracranial neoplasms. Cancer 53:426-429, 1984
34. McLean TW, Ringold S, Neuberg D, et al: TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252-4258, 1996
35. Rubnitz JE, Downing JR, Pui CH, et al: Tel gene rearrangement in acute lymphoblastic leukemia: A new genetics marker with prognostic significance. J Clin Oncol 15:1150-1157, 1997
36. Malkin D, Li FP, Strong LC, et al: Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
37. Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847, 1995
38. Morehead JM, Parsons DS, McMahon DP: Squamous cell carcinoma of the tongue occurring as a subsequent malignancy in a 12-year-old acute leukemia survivor. Int J Pediatr Otorhinolaryngol 26:89-94, 1993
39. Meadows AT, D'Angio GJ, Mike V, et al: Patterns of second malignant neoplasms in children. Cancer 40:1903-1911, 1977
40. Tang TT, Holcenberg JS. Duck SC, et al: Thyroid carcinoma following treatment for acute lymphoblastic leukemia. Cancer 46:1572-1576, 1980
41. Peeters MA, Smith C, Saunders EF: Secondary Hodgkin's disease in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 14:230-233, 1986
42. Blatt J, Olshan A, Gula MJ, et al: Second malignancies in very long term survivors of childhood cancer. Am J Med 93:57-60, 1992